Sorrento Therapeutics

Search
  • Who We Are
    • Overview
    • History
    • Leadership
    • Board of Directors
  • Research
    • Pipeline
    • COVID-19
    • Immunotherapy
    • Pain
    • Lymphatic Drug Delivery
    • Product Candidates
    • Clinical Trials
  • Manufacturing
  • Subsidiaries
  • Partnership
  • Investors
    • News & Events
      • Events Calendar
      • Presentations
    • SEC Filings
    • Stock
    • Governance
      • Overview
      • Committee Composition
    • Contact IR
  • Careers
  • Contact
en English▼
X
af Afrikaanssq Albanianam Amharicar Arabichy Armenianaz Azerbaijanieu Basquebe Belarusianbn Bengalibs Bosnianbg Bulgarianca Catalanceb Cebuanony Chichewazh-CN Chinese (Simplified)zh-TW Chinese (Traditional)co Corsicanhr Croatiancs Czechda Danishnl Dutchen Englisheo Esperantoet Estoniantl Filipinofi Finnishfr Frenchfy Frisiangl Galicianka Georgiande Germanel Greekgu Gujaratiht Haitian Creoleha Hausahaw Hawaiianiw Hebrewhi Hindihmn Hmonghu Hungarianis Icelandicig Igboid Indonesianga Irishit Italianja Japanesejw Javanesekn Kannadakk Kazakhkm Khmerko Koreanku Kurdish (Kurmanji)ky Kyrgyzlo Laola Latinlv Latvianlt Lithuanianlb Luxembourgishmk Macedonianmg Malagasyms Malayml Malayalammt Maltesemi Maorimr Marathimn Mongolianmy Myanmar (Burmese)ne Nepalino Norwegianps Pashtofa Persianpl Polishpt Portuguesepa Punjabiro Romanianru Russiansm Samoangd Scottish Gaelicsr Serbianst Sesothosn Shonasd Sindhisi Sinhalask Slovaksl Slovenianso Somalies Spanishsu Sudanesesw Swahilisv Swedishtg Tajikta Tamilte Teluguth Thaitr Turkishuk Ukrainianur Urduuz Uzbekvi Vietnamesecy Welshxh Xhosayi Yiddishyo Yorubazu Zulu

Common Stock

Common-Stock-filed-on-4-11-2017

Common Stock

Common-Stock-filed-on-4-11-17

Prospectus Supplement No. 1

Prospectus-Supplement-No.-1-filed-on-8/18/19

14-A

Schedule-14A-filed-on-6-8-16

DEF 14A

168972ACL

DEF 14A

896142-Sorrento-Therapeutics-2015-Proxy-bmk

Amended Request

815192-005_AS-FILED_CORRESP_EDGAR_NO_BANNERS

PROSPECTUS SUPPLEMENT NO. 2

826919-002_AS-FILED_424B3_PROSPECTUS_SUPPLEMENT_NO_2_EDGAR_NO_BANNERS

Prospectus Supplement

Sorrento-424b3-As-filed

Proxy Statement

713783_SRNE_DEF14A_AS_FILED

© 2023 Sorrento Therapeutics, Inc. All Rights Reserved. Terms of Use | Forward Looking Statements | Privacy Policy | Cookie Policy | Notices
logo
  • Who We Are
    • Overview
    • History
    • Leadership
    • Board of Directors
  • Research
    • Pipeline
    • COVID-19
    • Immunotherapy
    • Pain
    • Lymphatic Drug Delivery
    • Product Candidates
    • Clinical Trials
  • Manufacturing
  • Subsidiaries
  • Partnership
  • Investors
    • News & Events
      • Events Calendar
      • Presentations
    • SEC Filings
    • Stock
    • Governance
      • Overview
      • Committee Composition
    • Contact IR
  • Careers
  • Contact